Myomo (MYO) FCF Margin (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,326.00 |
| Jun 30, 2025 | -8,459.00 |
| Mar 31, 2025 | -4,799.00 |
| Dec 31, 2024 | 4,047.00 |
| Sep 30, 2024 | 735.00 |
| Jun 30, 2024 | 6,098.00 |
| Mar 31, 2024 | -3,785.00 |
| Dec 31, 2023 | -1,537.00 |
| Sep 30, 2023 | -2,978.00 |
| Jun 30, 2023 | 4,897.00 |
| Mar 31, 2023 | 704.00 |
| Dec 31, 2022 | 962.00 |
| Sep 30, 2022 | 277.00 |
| Jun 30, 2022 | -1,210.00 |
| Mar 31, 2022 | -1,539.00 |
| Dec 31, 2021 | 592.00 |
| Sep 30, 2021 | 6,379.00 |
| Jun 30, 2021 | -2,333.00 |
| Mar 31, 2021 | -6,203.00 |
| Dec 31, 2020 | 6,429.00 |
| Sep 30, 2020 | 33,111.00 |
| Jun 30, 2020 | -18,239.00 |
| Mar 31, 2020 | -6,853.00 |
| Dec 31, 2019 | 20,332.00 |
| Sep 30, 2019 | -11,491.00 |
| Jun 30, 2019 | 11,332.00 |
| Mar 31, 2019 | -9,295.00 |
| Dec 31, 2018 | 13,006.00 |
| Sep 30, 2018 | -4,018.00 |
| Jun 30, 2018 | 37,063.00 |
| Mar 31, 2018 | 131,916.00 |
| Dec 31, 2017 | -168,117.00 |
| Sep 30, 2017 | 13,508.00 |
| Jun 30, 2017 | 578,562.00 |
| Mar 31, 2017 | -610,104.00 |
| Dec 31, 2016 | 51,184.00 |